ENDIA

New Australian research highlights the benefits of continuous glucose monitoring ( ) during pregnancy for women living with type 1 diabetes.

Here we report on the first population-based Australian study of its kind, including the contribution of a significant number of mothers participating in the ENDIA Study. Researchers found women using CGM experienced greater improvements in blood glucose control during pregnancy compared with those not using CGM.

These findings closely matched results from previous international clinical trials (e.g. CONCEPTT), showing CGM can help support glucose levels throughout pregnancy.

The study also reinforced the importance of glucose management before conception, as early pregnancy HbA1c was the strongest predictor of glucose outcomes later in pregnancy.

While CGM improved glycaemic management, challenges remain. Rates of babies being born larger than expected and neonatal complications were still higher when compared to the general population. This highlights the need for continued research and support for families affected by type 1 diabetes.

These real-world findings provide reassuring evidence that CGM is an important tool for diabetes management during and supporting optimal outcomes for mothers and babies.

Read more at: https://doi.org/10.1177/15209156261455567

And BIG thanks to Jess for sending us this beautiful photo of her pregnancy

This dynamic duo, Hazel and Maya, have been helping ENDIA since they were babies! And now here they are in primary school and growing up into two terrific gals.

Double samples, double contributions with special thanks to mum for helping to collect them all and bring the girls to see nurse Rose.

Thanks so much ladies for all your valuable help to find the cause/s of We couldn't do it without you.